-
New drug Baochang (polycarboside calcium tablets) of Xinhua Pharmaceutical Group 3.1 will be on the market soon
Time of Update: 2014-06-22
Baochang (polycarbonate non calcium tablets) is used to improve the gastrointestinal symptoms such as constipation, diarrhea, abdominal pain and abdominal distention in IBS, and also can be used for c
-
A new stone medicine, enbep, won the China Industrial award and will carry out clinical trials in the United States
Time of Update: 2014-06-17
The "enbip" product China Industrial award is the highest award in China's industrial field approved and established by the State Council It represents the direction, road and spirit of China's indust
-
May 2014 CDE drug review report
Time of Update: 2014-06-10
Recently, the insight data team of dingxiangyuan sorted out and analyzed the registration applications of drugs accepted by CDE in May 2014, with a total number of 802 applications (calculated by acce
-
Haizheng Pfizer international production base officially put into production to create high-end generic drugs
Time of Update: 2014-05-29
Mr Xiao Weihong, chief executive officer of Haizheng Pfizer Pharmaceutical Co., Ltd., presented the first box of drugs put into production to the parent company, Haizheng Pfizer Fuyang production base
-
Rhodium (Ⅲ), a new metal complex developed by Hong Kong Baptist University, can treat skin cancer
Time of Update: 2014-05-20
Dr madilong pointed out that the newly developed complex is expected to further develop into an effective anti-tumor drug, and scholars from Hong Kong, Macao and Taiwan will work together to develop a
-
Phase III clinical trial of Zhongzhu 1018, an anticancer drug jointly developed by Qianjiang pharmaceutical and TnI
Time of Update: 2014-05-17
In October 2012, Qianjiang pharmaceutical, a subsidiary of China Pearl holdings, signed a cooperation agreement with TnI Biotechnology Co., Ltd (US) to jointly develop preclinical research on blood, b
-
Vsg-22, a new anti-inflammatory drug based on structure, was discovered by Shanghai Pharmaceutical Research Institute
Time of Update: 2014-05-10
The structure based anti-inflammatory candidate drug vsg-22 glucocorticoid receptor (GR) is a hot target for the development of anti-inflammatory drugs Up to now, glucocorticoids developed with the ta
-
Fosun medicine is authorized exclusively by pamz, a new tuberculosis drug in Greater China
Time of Update: 2014-04-29
At present, Fosun medicine has completed the second phase of clinical treatment and is ready to enter the third phase of global clinical trials According to the agreement, Fosun Pharmaceutical will su
-
Taiwan's new drugs will be on the market in the mainland as soon as the end of the year
Time of Update: 2014-04-10
Xu Mingneng, vice president of the Ministry of health and welfare, said that at present, one new drug in Taiwan has completed three phases of clinical trials and entered the stage of final inspection,
-
CFDA approves the listing of highly selective central antiemetic arepidem
Time of Update: 2014-04-02
Chemotherapy is an important treatment for many cancer patients Nausea and vomiting (CINV) caused by chemotherapy is the most common adverse reactions, which may lead to metabolic disorders, damage to
-
The industrialization of bezoar in vitro
Time of Update: 2014-03-31
Yesterday, Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd was busy in the in vitro cultivation of bezoar production line in Xin'andu, East and West Lake District In the fermentation workshop, the "steel
-
The formulation of wild medicinal fungi is expected to be a new antitumor drug
Time of Update: 2014-03-29
In December 2013, the Department of biology and pharmaceutics of the Department of rescue medicine of the Logistics College of the Chinese armed police carried out a systematic screening experiment on
-
Guangyao group introduces three new anti-tumor drugs under development
Time of Update: 2014-03-27
According to reports, the innovation team selected this time is the first innovation team of Guangdong Province obtained by Guangyao group There are seven core members The team has been engaged in the
-
Long acting growth hormone is expected to increase adult anti-aging indications
Time of Update: 2014-03-22
It is understood that the preclinical detection of the indication has been completed, and Kinsey pharmaceutical will apply to the State Food and Drug Administration for the third phase of clinical tri
-
Tonghua Dongbao Protamine Recombinant Human Insulin mixed injection Ganshulin R40 (40 / 60) obtained the approval of new drug
Time of Update: 2014-03-18
As the first product of this specification in the domestic insulin market, it not only marks the strong rise of domestic brands in the insulin market, but also the company will soon put this product o
-
Rao Zihe and his team have applied for clinical application of new drugs for HFMD
Time of Update: 2014-03-14
Two years ago, Rao Zihe and his team developed the structure of HFMD virus, and found that the virus has two structures: hollow and solid The hollow virus with more than 90 holes on its surface is res
-
Guizhou bailing Tangning Tongluo capsule obtained clinical research approval
Time of Update: 2014-03-13
Guizhou bailing water test diabetes research and development started last year In April 2013, the company paid 5 million yuan to Yang Guoshun and Yang Ailong to purchase the Miao medicine formula Acco
-
Haiwang's biological anti-tumor drugs are on the market
Time of Update: 2014-03-06
Among them, gemcitabine and otilacy potassium are one-half of the anticancer drug s-1, which can inhibit the toxic and side effects of the anticancer drug tegafur More worthy of attention is the use o
-
Anke biological acquires a new drug of burn and scald, freeze-dried recombinant human keratinocyte growth factor-2
Time of Update: 2014-02-25
In order to purchase the new KGF-2 for burn wound healing, Anke biology announced that it would invest in Anhui xinhuakun Bioengineering Co., Ltd (hereinafter referred to as xinhuakun), purchase 100%
-
Hanyu pharmaceutical major new drug creation project "kilogram peptide drug preparation pilot test technology platform" passed the acceptance
Time of Update: 2014-02-11
From the research and development of Hanyu pharmaceutical in the past year, the company's R & D strength in peptide drug synthesis has attracted the attention of the market In the past more than one y
